It really is hard to understand. The only plausib
Post# of 145730
![](/assets/46931549/no_avatar_available_thumb.jpg)
The issue with this perspective is that they have not shown in any of the prior EUA that they have put their ducks in a row prior to announcing.
Perhaps they didnt need to dive into manufacturing and distribution with the other EUA, because they were from established pharma companies?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)